Galera Therapeutics
http://www.ipharminc.com/new-blog/2019/12/4/coverage-indicates-3x-greater-revenue-potential-for-brilacidin-oral-rinse
http://finance.yahoo.com/news/analysts-galera-novel-pipeline-radiation-181005144.html
- Forums
- ASX - General
- Research Reports
Research Reports, page-434
Featured News
Featured News
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online